Sagimet Biosciences (SGMT) Enterprise Value: 2023-2024
Historic Enterprise Value for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to -$63.3 million.
- Sagimet Biosciences' Enterprise Value fell 163.65% to -$63.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$518.3 million, marking a year-over-year decrease of 357.46%. This contributed to the annual value of $144.9 million for FY2024, which is 396.18% up from last year.
- Latest data reveals that Sagimet Biosciences reported Enterprise Value of -$63.3 million as of Q3 2024, which was down 10.62% from -$57.2 million recorded in Q2 2024.
- Sagimet Biosciences' Enterprise Value's 5-year high stood at $99.5 million during Q3 2023, with a 5-year trough of -$63.3 million in Q3 2024.
- Over the past 2 years, Sagimet Biosciences' median Enterprise Value value was -$19.6 million (recorded in 2023), while the average stood at -$5.2 million.
- Data for Sagimet Biosciences' Enterprise Value shows a maximum YoY slumped of 209.20% (in 2024) over the last 5 years.
- Sagimet Biosciences' Enterprise Value (Quarterly) stood at $29.2 million in 2023, then tumbled by 163.65% to -$63.3 million in 2024.
- Its last three reported values are -$63.3 million in Q3 2024, -$57.2 million for Q2 2024, and -$20.7 million during Q1 2024.